BioCardia, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
BioCardia, Inc. (BCDA) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $320.00 thousand for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-10-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2016-10-17
- BioCardia, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2016-09-30 was $330.00K.
- BioCardia, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- BioCardia, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2016-03-31 was -$10.00K.
- BioCardia, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2015-12-31 was $10.00K.
- BioCardia, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2015 was $9.00K.
- BioCardia, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2014 was -$17.00K, a 383.33% decline from fiscal 2013.
- BioCardia, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2013 was $6.00K.
- BioCardia, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2012 was -$744.00K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 15 month |
|---|---|---|---|---|---|---|
| 2016-09-30 | $330.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-17 | $330.00K derived: sum of 2 quarters · filed 2016-10-17 | $320.00K 10-Q · filed 2016-10-17 | $330.00K derived: sum of 4 quarters · filed 2016-10-17 | ||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | -$10.00K 10-Q · filed 2016-08-02 | $0.00 derived: sum of 3 quarters · filed 2016-08-02 | -$4.00K derived: sum of 4 quarters · filed 2016-10-17 | ||
| 2016-03-31 | -$10.00K 10-Q · filed 2016-05-03 | $0.00 derived: sum of 2 quarters · filed 2016-05-03 | -$4.00K derived: sum of 3 quarters · filed 2016-10-17 | $0.00 derived: sum of 4 quarters · filed 2016-10-17 | ||
| 2015-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $6.00K derived: sum of 2 quarters · filed 2016-10-17 | $10.00K derived: sum of 3 quarters · filed 2016-10-17 | $9.00K 10-K · filed 2016-03-25 | ||
| 2015-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-17 | $0.00 derived: sum of 2 quarters · filed 2016-10-17 | -$1.00K 10-Q · filed 2016-10-17 | -$5.00K derived: sum of 4 quarters · filed 2016-10-17 | ||
| 2015-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | $3.00K 10-Q · filed 2016-08-02 | -$1.00K derived: sum of 3 quarters · filed 2016-08-02 | $3.00K derived: sum of 4 quarters · filed 2016-08-02 | ||
| 2015-03-31 | -$1.00K 10-Q · filed 2016-05-03 | -$5.00K derived: sum of 2 quarters · filed 2016-05-03 | -$1.00K derived: sum of 3 quarters · filed 2016-05-03 | -$1.00K derived: sum of 4 quarters · filed 2016-05-03 | ||
| 2014-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $0.00 derived: sum of 2 quarters · filed 2016-03-25 | $0.00 derived: sum of 3 quarters · filed 2016-03-25 | -$17.00K 10-K · filed 2016-03-25 | ||
| 2014-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $4.00K derived: sum of 2 quarters · filed 2015-10-29 | -$13.00K 10-Q · filed 2015-10-29 | $2.00K derived: sum of 4 quarters · filed 2015-10-29 | ||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$17.00K 10-Q · filed 2015-08-12 | -$2.00K derived: sum of 3 quarters · filed 2015-08-12 | -$2.00K derived: sum of 4 quarters · filed 2015-08-12 | ||
| 2014-03-31 | -$17.00K 10-Q · filed 2015-05-12 | -$2.00K derived: sum of 2 quarters · filed 2015-05-12 | -$2.00K derived: sum of 3 quarters · filed 2015-05-12 | -$9.00K derived: sum of 4 quarters · filed 2015-05-12 | -$11.00K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-24 | $15.00K derived: sum of 2 quarters · filed 2015-03-24 | $8.00K derived: sum of 3 quarters · filed 2015-03-24 | $6.00K 10-K · filed 2015-03-24 | ||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$7.00K derived: sum of 2 quarters · filed 2014-11-06 | -$9.00K 10-Q · filed 2014-11-06 | -$138.00K derived: sum of 4 quarters · filed 2014-11-06 | ||
| 2013-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | -$9.00K 10-Q · filed 2014-08-06 | -$138.00K derived: sum of 3 quarters · filed 2014-08-06 | -$139.00K derived: sum of 4 quarters · filed 2014-08-06 | ||
| 2013-03-31 | -$2.00K 10-Q · filed 2014-05-12 | -$131.00K derived: sum of 2 quarters · filed 2014-05-12 | -$132.00K derived: sum of 3 quarters · filed 2014-05-12 | -$701.00K derived: sum of 4 quarters · filed 2014-05-12 | ||
| 2012-12-31 | -$129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-24 | -$130.00K derived: sum of 2 quarters · filed 2014-03-24 | -$699.00K derived: sum of 3 quarters · filed 2014-03-24 | -$744.00K 10-K · filed 2014-03-24 | ||
| 2012-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | -$570.00K derived: sum of 2 quarters · filed 2013-11-01 | -$615.00K 10-Q · filed 2013-11-01 | -$1.16M derived: sum of 4 quarters · filed 2013-11-01 | ||
| 2012-06-30 | -$569.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-26 | -$614.00K 10-Q · filed 2013-07-26 | -$1.16M derived: sum of 3 quarters · filed 2013-07-26 | -$1.24M derived: sum of 4 quarters · filed 2013-07-26 | ||
| 2012-03-31 | -$45.00K 10-Q · filed 2013-05-10 | -$589.00K derived: sum of 2 quarters · filed 2013-05-10 | -$675.00K derived: sum of 3 quarters · filed 2013-05-10 | -$1.14M derived: sum of 4 quarters · filed 2013-05-10 | ||
| 2011-12-31 | -$544.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-22 | -$630.00K derived: sum of 2 quarters · filed 2013-03-22 | -$1.09M derived: sum of 3 quarters · filed 2013-03-22 | -$1.46M 10-K · filed 2013-03-22 | ||
| 2011-09-30 | -$86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$547.00K derived: sum of 2 quarters · filed 2012-11-08 | -$912.00K 10-Q · filed 2012-11-08 | -$1.16M derived: sum of 4 quarters · filed 2012-11-08 | ||
| 2011-06-30 | -$461.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | -$826.00K 10-Q · filed 2012-08-10 | -$1.39M 10-Q · filed 2011-08-11 | -$1.07M derived: sum of 3 quarters · filed 2012-08-10 | -$1.05M derived: sum of 4 quarters · filed 2012-08-10 | |
| 2011-03-31 | -$365.00K 10-Q · filed 2012-05-15 | -$614.00K derived: sum of 2 quarters · filed 2012-05-15 | -$593.00K derived: sum of 3 quarters · filed 2012-05-15 | |||
| 2010-12-31 | -$249.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | -$228.00K derived: sum of 2 quarters · filed 2012-03-29 | $805.00K 10-K · filed 2012-03-29 | |||
| 2010-09-30 | $21.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-15 | $1.05M 10-Q · filed 2011-11-15 | ||||
| 2010-06-30 | $1.03M 10-Q/A · filed 2011-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |